Ovarian PRP Injections for Improved Embryo Quality Using Embryo Quality Score
Recruiting now · Not applicable
Conditions studied: Infertility, Poor Ovarian Reserve, Embryo Growth Disorder, in Vitro Fertilization
In brief
Patients will have ovarian PRP treatments and embryo development will be observed using time-lapse imaging and AI software.
Key facts
- Study ID
- NCT07020546
- Run by
- Generation Next Fertility
- People needed
- 180
- Starts
- 2025-07-08
- Expected to finish
- 2026-08-30
- Last updated by the study team
- 2025-07-09
Who can join
Age: 18 and older, up to 47. Sex: female. Healthy volunteers: accepted.
You may qualify if…
- No none contraindications to IVF or PRP treatment
- Adequate ovarian reserves and AMH level
- Willingness to undergo two IVF cycles and oPRP treatment
You may not qualify if…
- Anovulation due to menopause or perimenopause
- Any health conditions that are contraindicated for IVF or oPRP treatment
Where it is running
- Generation Next Fertility — New York, New York, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.